PG
The Procter & Gamble Company NYSE$143.45
Mkt Cap $334.0B
52w Low $137.62
17.5% of range
52w High $170.99
50d MA $149.53
200d MA $150.68
P/E (TTM)
22.1x
EV/EBITDA
17.4x
P/B
6.9x
Debt/Equity
0.7x
ROE
—
P/FCF
27.8x
RSI (14)
—
ATR (14)
—
Beta
0.40
50d MA
$149.53
200d MA
$150.68
Avg Volume
10.7M
About
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal c…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | TNS | 1.56 | 1.59 | +1.9% | 148.18 | -0.5% | +0.1% | +0.7% | -1.2% | -0.7% | -0.6% | — | — |
| Jan 22, 2026 | TNS | 1.86 | 1.88 | +1.1% | 149.93 | +0.6% | +0.1% | -0.3% | -1.1% | -1.7% | -0.0% | +10.2% | — |
| Oct 24, 2025 | TNS | 1.90 | 1.99 | +4.7% | 152.49 | -0.6% | -0.5% | -0.7% | -2.4% | -1.9% | -1.4% | -3.6% | — |
| Jul 29, 2025 | TNS | 1.42 | 1.48 | +4.2% | 156.61 | +0.2% | -2.4% | -3.9% | -3.8% | -3.7% | -3.9% | -0.6% | — |
| Apr 24, 2025 | TNS | 1.52 | 1.54 | +1.3% | 159.53 | +0.2% | +0.9% | +1.5% | +1.7% | +1.9% | +0.3% | +5.2% | — |
| Jan 22, 2025 | TNS | 1.89 | 1.88 | -0.5% | 164.74 | -0.5% | +0.9% | -0.4% | +3.0% | +0.9% | +0.9% | +3.3% | — |
| Oct 18, 2024 | TNS | 1.90 | 1.93 | +1.6% | 171.28 | -0.2% | -1.0% | -0.9% | -1.0% | -1.0% | -1.8% | -0.3% | — |
| Jul 30, 2024 | TNS | 1.37 | 1.40 | +2.2% | 161.70 | -0.6% | -0.6% | +2.5% | +5.2% | +3.9% | +4.0% | +5.2% | — |
| Apr 19, 2024 | TNS | 1.41 | 1.52 | +7.8% | 158.14 | +0.2% | +1.5% | +2.1% | +2.8% | +2.8% | +2.0% | +5.8% | — |
| Jan 23, 2024 | TNS | 1.70 | 1.84 | +8.2% | 153.98 | -0.0% | -1.2% | +1.1% | +1.4% | +1.4% | +2.3% | +4.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | UBS | Maintains | Buy → Buy | — | $148.18 | $147.42 | -0.5% | +0.1% | +0.7% | -1.2% | -0.7% | -0.6% |
| Apr 27 | TD Cowen | Maintains | Hold → Hold | — | $148.18 | $147.42 | -0.5% | +0.1% | +0.7% | -1.2% | -0.7% | -0.6% |
| Apr 27 | Wells Fargo | Maintains | Overweight → Overweight | — | $148.18 | $147.42 | -0.5% | +0.1% | +0.7% | -1.2% | -0.7% | -0.6% |
| Apr 27 | Evercore ISI | Maintains | In Line → In Line | — | $148.18 | $147.42 | -0.5% | +0.1% | +0.7% | -1.2% | -0.7% | -0.6% |
| Apr 17 | JP Morgan | Maintains | Overweight → Overweight | — | $143.11 | $143.41 | +0.2% | +2.7% | +1.0% | -0.6% | -0.2% | +1.8% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $143.58 | $143.24 | -0.2% | +0.6% | -0.1% | -0.3% | +2.3% | +0.6% |
| Apr 10 | BofA Securities | Maintains | Buy → Buy | — | $146.66 | $146.89 | +0.2% | -1.0% | -2.1% | -1.6% | -2.2% | -2.4% |
| Apr 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $141.30 | $143.15 | +1.3% | +2.5% | +3.8% | +2.7% | +1.6% | +2.2% |
| Apr 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $141.30 | $143.15 | +1.3% | +2.5% | +3.8% | +2.7% | +1.6% | +2.2% |
| Apr 7 | UBS | Maintains | Buy → Buy | — | $142.77 | $142.52 | -0.2% | -1.0% | +1.5% | +2.7% | +1.7% | +0.6% |
Recent Filings
8-K
Procter & Gamble Company -- 8-K Filing
Procter & Gamble's diluted earnings per share grew 6% to $1.63, benefiting from a gain on dissolving its Glad joint venture partnership.
Apr 24
8-K · 7.01
! Medium
Procter & Gamble Company -- 8-K 7.01: Regulation FD Disclosure
Procter & Gamble disclosed investor presentation slides from a recent conference call, providing shareholders with updated company information and guidance available on its website.
Apr 24
P&G CFO Andre Schulten on Q3 results: We are building broad-based momentum
Apr 24
Stocks making the biggest moves premarket: Intel, Advanced Micro Devices, Procter & Gamble & more
Apr 24
Procter & Gamble earnings beat estimates as sales grow 7%
Apr 24
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Procter & Gamble's 3% dividend increase signals management confidence in sustained cash generation and rewards shareholders with higher income, making PG attractive for dividend-focused investors seeking stable returns.
Apr 14
Data updated apr 26, 2026 7:27pm
· Source: massive.com